Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
J Vet Med Sci ; 82(2): 188-192, 2020 Feb 18.
Artigo em Inglês | MEDLINE | ID: mdl-31875599

RESUMO

East Coast fever is caused by Theileria parva, and poses serious concerns for dairy farmers owing to massive economic losses. In the current study, we compared three methods (DNA extraction kits, FTA-NaOH and FTA-TENT) of DNA extraction to identify the most economical and reliable method. A survey for T. parva prevalence was conducted in dairy cattle in Mbarara, Uganda. Cytochrome C oxidase subunit I (COI) and T. parva-p104 genes were amplified to compare the methods. FTA-NaOH-based polymerase chain reaction (PCR) yielded the best detection rate for both COI gene and p104 gene. Prevalence of T. parva was 45.0% and 83.3% at animal and farm-level, respectively. FTA-NaOH based-PCR is simple, highly sensitive and cost-effective tool for T. parva diagnosis in resource constrained settings.


Assuntos
Doenças dos Bovinos/diagnóstico , Reação em Cadeia da Polimerase/veterinária , Theileria parva/isolamento & purificação , Theileriose/diagnóstico , Animais , Bovinos , Doenças dos Bovinos/sangue , Doenças dos Bovinos/parasitologia , DNA/análise , DNA/isolamento & purificação , Indústria de Laticínios , Papel , Reação em Cadeia da Polimerase/economia , Reação em Cadeia da Polimerase/métodos , Prevalência , Hidróxido de Sódio , Manejo de Espécimes/instrumentação , Theileria parva/genética , Theileriose/sangue , Theileriose/epidemiologia , Uganda
2.
PLoS Pathog ; 3(10): 1401-13, 2007 Oct 19.
Artigo em Inglês | MEDLINE | ID: mdl-17953480

RESUMO

Babesia bovis is an apicomplexan tick-transmitted pathogen of cattle imposing a global risk and severe constraints to livestock health and economic development. The complete genome sequence was undertaken to facilitate vaccine antigen discovery, and to allow for comparative analysis with the related apicomplexan hemoprotozoa Theileria parva and Plasmodium falciparum. At 8.2 Mbp, the B. bovis genome is similar in size to that of Theileria spp. Structural features of the B. bovis and T. parva genomes are remarkably similar, and extensive synteny is present despite several chromosomal rearrangements. In contrast, B. bovis and P. falciparum, which have similar clinical and pathological features, have major differences in genome size, chromosome number, and gene complement. Chromosomal synteny with P. falciparum is limited to microregions. The B. bovis genome sequence has allowed wide scale analyses of the polymorphic variant erythrocyte surface antigen protein (ves1 gene) family that, similar to the P. falciparum var genes, is postulated to play a role in cytoadhesion, sequestration, and immune evasion. The approximately 150 ves1 genes are found in clusters that are distributed throughout each chromosome, with an increased concentration adjacent to a physical gap on chromosome 1 that contains multiple ves1-like sequences. ves1 clusters are frequently linked to a novel family of variant genes termed smorfs that may themselves contribute to immune evasion, may play a role in variant erythrocyte surface antigen protein biology, or both. Initial expression analysis of ves1 and smorf genes indicates coincident transcription of multiple variants. B. bovis displays a limited metabolic potential, with numerous missing pathways, including two pathways previously described for the P. falciparum apicoplast. This reduced metabolic potential is reflected in the B. bovis apicoplast, which appears to have fewer nuclear genes targeted to it than other apicoplast containing organisms. Finally, comparative analyses have identified several novel vaccine candidates including a positional homolog of p67 and SPAG-1, Theileria sporozoite antigens targeted for vaccine development. The genome sequence provides a greater understanding of B. bovis metabolism and potential avenues for drug therapies and vaccine development.


Assuntos
Babesia bovis/genética , DNA de Protozoário/análise , Genes de Protozoários , Plasmodium falciparum/genética , Theileria parva/genética , Animais , Antígenos de Protozoários/imunologia , Babesia bovis/imunologia , Babesia bovis/metabolismo , Babesiose/parasitologia , Sequência de Bases , Proteínas de Transporte/genética , Proteínas de Transporte/imunologia , Proteínas de Transporte/metabolismo , Cromossomos , DNA Complementar/análise , Evolução Molecular , Biblioteca Genômica , Dados de Sequência Molecular , Plasmodium falciparum/imunologia , Plasmodium falciparum/metabolismo , Proteínas de Protozoários/genética , Proteínas de Protozoários/imunologia , Proteínas de Protozoários/metabolismo , Análise de Sequência de DNA , Especificidade da Espécie , Sintenia , Theileria parva/imunologia , Theileria parva/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA